Funding deal between Bavarian Nordic and Ministry of Health approved by Danish parliament

The Danish Parliament's Finance Committee has cleared the funding agreement between Bavarian Nordic and the Danish Ministry of Health concerning the biotech company's Covid-19 vaccine candidate.

Photo: Philip Davali/Ekstra Bladet, Philip Davali

The Finance Committee of the Danish Parliament has approved plans to support the development of Bavarian Nordic's Covid-19 vaccine.

The deal, formally made between Bavarian Nordic and the Danish Ministry of Health, will allow the biotech company access to DKK 800m (USD 160m) in financial aid to finalize its clinical study of the vaccine, currently undergoing a phase II trial.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Lundbeck chairman demands change: "We can't live with this"

Years of work developing new treatments at Lundbeck has so far come to nothing. This has led chairman Lars Rasmusssen to demand visible results, even though CEO Deborah Dunsire has essentially had to restart development work since she joined the firm in 2018.

Eli Lilly upgrades earnings per share guidance

On Tuesday, US-based pharmaceutical firm Eli Lilly has updated elements of its 2021 financial guidance pertaining to earnings per share (non-GAAP), now expecting USD 7.95-8.05 compared to the previous USD 7.8-8.

Further reading

Related articles

Trial banner

Latest news

See all jobs